UNSPSC 51352211: Hexestrol diphosphate sodium

This classification denotes a non-steroidal estrogen with the molecular formula C18H20O8P2.4Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VK60X9E36E, chemically known as phenol, 4,4'-((1r,2s)-1,2-diethyl-1,2-ethanediyl)bis-, bis(dihydrogen phosphate), tetrasodium salt, rel-, but more generally known as hexestrol diphosphate sodium, which bears US NIH Compound Identifier 3064060.

European Medicines Agency schedules hexestrol diphosphate sodium or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08036MIG. Most nations, for tariff purposes, schedule hexestrol diphosphate sodium under HS 29072900. SMILES: CC[C@H](C1CCC(CC1)OP(=O)([O-])[O-])[C@@H](CC)C2CCC(CC2)OP(=O)([O-])[O-].[NA+].[NA+].[NA+].[NA+].

UNSPSC 51352211 Hexestrol diphosphate sodium is a Commodity code for a pharmaceutical active ingredient with minimal recent state and local procurement activity in the available record.

The code represents a specific synthetic estrogen compound historically used in veterinary and pharmaceutical applications, though modern state and local health departments, correctional systems, and public health agencies rarely solicit it as a standalone procurement item. When pharmaceutical ingredients appear in state and local RFPs and RFQs, they typically surface as components of finished-form medications, compounded preparations, or bulk pharmaceutical supplies bundled under broader Family or Class codes rather than at the Commodity level. The absence of traceable recent opportunities under this specific code suggests either minimal current demand from public bodies, procurement bundling at higher UNSPSC tiers, or shift toward alternative formulations and suppliers in the pharmaceutical supply chain.

No recent state and local contract opportunities appear in the available record for this Commodity code.